Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

1.

Diagnostic role of survivin in urinary bladder cancer.

Srivastava AK, Singh PK, Srivastava K, Singh D, Dalela D, Rath SK, Goel MM, Brahma Bhatt ML.

Asian Pac J Cancer Prev. 2013;14(1):81-5.

PMID:
23534808
[PubMed - indexed for MEDLINE]
Free Article
2.

Predictive values of urinary bladder tumor markers survivin and soluble-Fas comparison with cystoscopy and bladder tumor antigen.

Ganas V, Kalaitzis C, Sountoulides P, Giannakopoulos S, Touloupidis S.

Minerva Urol Nefrol. 2012 Dec;64(4):279-85.

PMID:
23288215
[PubMed - indexed for MEDLINE]
3.

Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.

Svatek RS, Herman MP, Lotan Y, Casella R, Hsieh JT, Sagalowsky AI, Shariat SF.

Cancer. 2006 Apr 15;106(8):1701-7.

PMID:
16541433
[PubMed - indexed for MEDLINE]
Free Article
4.

Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.

May M, Hakenberg OW, Gunia S, Pohling P, Helke C, Lübbe L, Nowack R, Siegsmund M, Hoschke B.

Urology. 2007 Sep;70(3):449-53. Epub 2007 Aug 3.

PMID:
17688921
[PubMed - indexed for MEDLINE]
5.

Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.

Gilbert SM, Veltri RW, Sawczuk A, Shabsigh A, Knowles DR, Bright S, O'Dowd GJ, Olsson CA, Benson MC, Sawczuk IS.

Urology. 2003 Mar;61(3):539-43.

PMID:
12639642
[PubMed - indexed for MEDLINE]
6.

Combinations of urine-based tumour markers in bladder cancer surveillance.

Horstmann M, Patschan O, Hennenlotter J, Senger E, Feil G, Stenzl A.

Scand J Urol Nephrol. 2009;43(6):461-6. doi: 10.3109/00365590903296837.

PMID:
19903092
[PubMed - indexed for MEDLINE]
7.

Evaluation of urinary XIAP as a diagnostic biomarker of carcinoma of urinary bladder.

Srivastava AK, Singh PK, Singh D, Dalela D, Rath SK, Goel MM, Bhatt ML.

Tumour Biol. 2014 Aug;35(8):8243-8. doi: 10.1007/s13277-014-2026-6. Epub 2014 May 23.

PMID:
24852426
[PubMed - indexed for MEDLINE]
8.

Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.

Shariat SF, Herman MP, Casella R, Lotan Y, Karam JA, Stenman UH.

Eur Urol. 2005 Sep;48(3):424-31.

PMID:
15963628
[PubMed - indexed for MEDLINE]
9.

Testing for urinary hyaluronate improves detection and grading of transitional cell carcinoma.

Passerotti CC, Srougi M, Bomfim AC, Martins JR, Leite KR, Dos Reis ST, Sampaio LO, Ortiz V, Dietrich CP, Nader HB.

Urol Oncol. 2011 Nov-Dec;29(6):710-5. doi: 10.1016/j.urolonc.2009.10.006. Epub 2009 Dec 4.

PMID:
19962919
[PubMed - indexed for MEDLINE]
10.

Urinary survivin mRNA expression and urinary nuclear matrix protein 22 BladderChek® and urine cytology in the detection of transitional cell carcinoma of the bladder.

Al-Maghrebi M, Kehinde EO, Kapila K, Anim JT.

Med Princ Pract. 2012;21(3):295-7. doi: 10.1159/000334811. Epub 2012 Jan 11.

PMID:
22236881
[PubMed - indexed for MEDLINE]
11.

A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results.

Poulakis V, Witzsch U, De Vries R, Altmannsberger HM, Manyak MJ, Becht E.

BJU Int. 2001 Nov;88(7):692-701.

PMID:
11890239
[PubMed - indexed for MEDLINE]
12.

[Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].

Friedrich MG, Hellstern A, Hautmann SH, Noldus I, Huland H.

Urologe A. 2003 Apr;42(4):523-30. Epub 2003 Jan 17. German.

PMID:
12715124
[PubMed - indexed for MEDLINE]
13.

[Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].

Fernández Gómez JM, García Rodríguez J, Escaf Barmadah S, Raigoso P, Rodríguez Martínez JJ, Allende MT, Casasola Chamorro J, Rodríguez Faba O, Martín Benito JL, Regadera Sejas FJ.

Arch Esp Urol. 2002 Jan-Feb;55(1):41-9. Spanish.

PMID:
11957750
[PubMed - indexed for MEDLINE]
14.

Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.

Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A.

J Urol. 2002 Aug;168(2):465-9.

PMID:
12131289
[PubMed - indexed for MEDLINE]
15.

Value of urinary survivin as a diagnostic marker in bladder cancer.

Abd El-Hakim TF, El-Shafie MK, Abdou AG, Azmy RM, El-Naidany SS, Badr El-Din MO.

Anal Quant Cytopathol Histpathol. 2014 Jun;36(3):121-7.

PMID:
25141488
[PubMed - indexed for MEDLINE]
16.

The addition of urinary urokinase-type plasminogen activator to urinary nuclear matrix protein 22 and cytology improves the detection of bladder cancer.

Shariat SF, Casella R, Monoski MA, Sulser T, Gasser TC, Lerner SP.

J Urol. 2003 Dec;170(6 Pt 1):2244-7.

PMID:
14634389
[PubMed - indexed for MEDLINE]
17.

Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors.

Giannopoulos A, Manousakas T, Mitropoulos D, Botsoli-Stergiou E, Constantinides C, Giannopoulou M, Choremi-Papadopoulou H.

Urology. 2000 Jun;55(6):871-5.

PMID:
10840098
[PubMed - indexed for MEDLINE]
18.

The value of combined use of survivin mRNA and matrix metalloproteinase 2 and 9 for bladder cancer detection in voided urine.

Eissa S, Badr S, Elhamid SA, Helmy AS, Nour M, Esmat M.

Dis Markers. 2013;34(1):57-62. doi: 10.3233/DMA-2012-0923.

PMID:
22960341
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

In the cystoscopic follow-up of non-muscle-invasive transitional cell carcinoma, NMP-22 works for high grades, but unreliable in low grades and upper urinary tract tumors.

Coskuner E, Cevik I, Ozkan A, Dillioglugil O, Akdas A.

Int Urol Nephrol. 2012 Jun;44(3):793-8. doi: 10.1007/s11255-012-0144-x. Epub 2012 Feb 28.

PMID:
22371126
[PubMed - indexed for MEDLINE]
20.

Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review.

Ku JH, Godoy G, Amiel GE, Lerner SP.

BJU Int. 2012 Sep;110(5):630-6. doi: 10.1111/j.1464-410X.2011.10884.x. Epub 2012 Feb 21. Review.

PMID:
22353238
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk